A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
Clinical trial NCT02308020 · COMPLETED
Trial details
- NCT number
- NCT02308020
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-20
- Primary completion
- 2018-11-08
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.